Heart Failure

Feb 9, 2017

About 5 million Americans are currently living with heart failure (HF) and an astounding 24-42% of them also suffer from depression.1,2 One meta-analysis found a greater than 2-fold risk of death in patients with HF and comorbid depression.  Depressed patients with HF are more likely to be hospitalized, seek care from emergency rooms, and rack up big bills.3  Not surprisingly, patients with HF and depression have a much lower quality of life when compared to HF patients

Comments: 0
May 20, 2016

Could a nutritional supplement be the “magic bullet” in heart failure therapy?  Coenzyme Q10 (CoQ10), or ubiquinone, is an electron carrier in mitochondria and plays a key role in ATP synthesis. It is also thought to have antioxidant effects and may stabilize LDL molecules. All of which would, theoretically, help the failing heart.1-3


Comments: 0
May 17, 2015

Could a commonly prescribed antibiotic, when combined with a renin-angiotensin system inhibitor, lead to sudden death?  Angiotensin converting enzyme inhibitors (ACE-I), angiotensin receptor blockers (ARB), and spironolactone are frequently used in older adults for a variety of indications.

Comments: 0
Jan 6, 2015

Digoxin is FDA-approved for the treatment of mild to moderate heart failure (HF) as well as the control of resting ventricular rate in adult patients with chronic atrial fibrillation (AF).1 Current guidelines recommend digoxin to control resting heart rate in patients with AF when they have concurrent HF.2 But does digoxin improve outcomes in patients with AF? The available data are conflicting and observational.3-6 Does the recently published TREAT-AF (The Re

Comments: 1
Nov 23, 2014

Heart failure not only causes disability and death but also millions of hospitalizations each year.1  The standard of care for patients with heart failure with reduced ejection fraction (HFrEF) includes a cocktail of drugs comprising an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) plus a beta-blocker and, in many cases, an aldosterone antagonist.1  The angiotensin receptor-neprilysin inhibitors (ARNIs) are a new class of drugs that

Comments: 1
Sep 29, 2013

A 65 year old patient presents to your clinic with an A1C of 7.2%, a blood pressure of 146/80 mmHg and a LDL cholesterol of 103 mg/dL. Should you order a BNP level to determine the patient’s risk of developing heart failure?

Comments: 1
Jan 3, 2012

Should elderly patients with heart failure receive beta-blockers?  SENIORS — a parallel group, randomized, double-blind, multi-center trial comparing nebivolol to placebo — attempted to answer this question.1  Concern about the tolerability of beta-blockers in elderly patients persists despite some evidence that they are likely safe in older adults with heart failure (HF).2,3,4  The current American Heart Association (AHA) guidelines recommend that all clinically stable patients with HF and r

Comments: 0
Mar 16, 2011

Are all of your patients with symptomatic heart failure and a low ejection fraction receiving an aldosterone antagonist?  Why not?

Comments: 5